Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Age > 18”

1,564 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,564 results

Testing effectiveness (Phase 2)Study completedNCT05868382
What this trial is testing

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA Vaccine Candidate Variations in Healthy Adults

Who this might be right for
Influenza
ModernaTX, Inc. 270
Not applicableStudy completedNCT06375525
What this trial is testing

Clinical Trial: The Efficacy of Janssen's Icon Application (App) in Improving Adherence to Treatment With Stimulant Medications in Children With Attention Deficit/Hyperactivity Disorder

Who this might be right for
Children Aged 6-18 Years With the Diagnosis of ADHD
Prof. Doron Gothelf MD 39
Large-scale testing (Phase 3)Looking for participantsNCT06875427
What this trial is testing

ACB vs no Block for Pediatric ACL Reconstruction

Who this might be right for
Anterior Cruciate LigamentAnterior Cruciate Ligament (ACL) Tear
Isabella Jaramillo 38
Large-scale testing (Phase 3)Study completedNCT05572879
What this trial is testing

A Phase III Study of COVID-19 Vaccine EuCorVac-19 in Healthy Adults

Who this might be right for
COVID-19
EuBiologics Co.,Ltd 2,600
Early research (Phase 1)Study completedNCT05762523
What this trial is testing

Safety and Tolerability Study of the VAC∆6 Vaccine in Volunteers Aged 18-40 Years

Who this might be right for
SmallpoxMonkeypoxCowpox+1 more
Federal Budgetary Research Institution State Research Center of Virology and Biotechnology "Vector" 60
Testing effectiveness (Phase 2)WithdrawnNCT01451450
What this trial is testing

Efficacy and Safety of 4 Doses of QGE031 in Patients 18-50 Years of Age With Peanut Allergy

Who this might be right for
Peanut Allergy
Novartis Pharmaceuticals
Large-scale testing (Phase 3)Study completedNCT04526990
What this trial is testing

Phase III Trial of A COVID-19 Vaccine of Adenovirus Vector in Adults 18 Years Old and Above

Who this might be right for
COVID-19
CanSino Biologics Inc. 44,247
Large-scale testing (Phase 3)Study completedNCT03493542
What this trial is testing

Evaluate the Immunogenicity, Safety and Tolerability of Quadrivalent Human Papillomavirus Vaccine (V501) in Chinese Girls Aged 9-19 Years and Young Women Aged 20-26 Years (V501-213)

Who this might be right for
Prevention of HPV Types 16- and 18-related Cervical Cancer, Cervical Intraepithelial Neoplasia (CIN) 1/2/3, and Cervical Adenocarcinoma in Situ
Merck Sharp & Dohme LLC 766
Testing effectiveness (Phase 2)Looking for participantsNCT05871970
What this trial is testing

Safety and Efficacy Study of Intracystic TARA-002 for the Treatment of Lymphatic Malformations in Participants 6 Months to Less Than 18 Years of Age

Who this might be right for
Lymphatic Malformation
Protara Therapeutics 38
Testing effectiveness (Phase 2)Study completedNCT01288573
What this trial is testing

A Combined Study in Pediatric Cancer Patients for Dose Ranging and Efficacy/Safety of Plerixafor Plus Standard Regimens for Mobilization Versus Standard Regimens Alone

Who this might be right for
Ewing's Sarcoma/Soft Tissue SarcomaNeuroblastomaBrain Tumors
Genzyme, a Sanofi Company 46
Large-scale testing (Phase 3)Study completedNCT02751931
What this trial is testing

Open-label Phase 3 Study With Mirabegron in Children From 3 to Less Than 18 Years of Age With Neurogenic Detrusor Overactivity

Who this might be right for
Neurogenic Detrusor Overactivity
Astellas Pharma Europe B.V. 91
Large-scale testing (Phase 3)Study completedNCT01389479
What this trial is testing

Study to Evaluate the Safety, Tolerance and Immunogenicity of Fluviral™ in Healthy Adults

Who this might be right for
Influenza
GlaxoSmithKline 1,000
Large-scale testing (Phase 3)Ended earlyNCT05643573
What this trial is testing

Learn How Well the Study Treatment Asundexian Works and How Safe it is Compared to Apixaban to Prevent Stroke or Systemic Embolism in People With Irregular and Often Rapid Heartbeat (Atrial Fibrillation), and at Risk for Stroke

Who this might be right for
Prevention of Stroke or Systemic EmbolismAtrial Fibrillation
Bayer 14,830
Large-scale testing (Phase 3)Study completedNCT03215056
What this trial is testing

Methoxyflurane Analgesia for Paediatric Injuries

Who this might be right for
Pain, Acute
Medical Developments International Limited 192
Testing effectiveness (Phase 2)Study completedNCT05373472
What this trial is testing

Phase II Clinical Trial of COVID-19 mRNA Vaccine in Adults Aged 18 Years and Older

Who this might be right for
COVID-19
CanSino Biologics Inc. 150
Early research (Phase 1)Study completedNCT01123941
What this trial is testing

Safety and Immunogenicity of Vi-CRM197 Vaccine Against S. Typhi in Adult (18-40 Years Old)

Who this might be right for
Typhoid Fever
Novartis 50
Not applicableUnknownNCT05547256
What this trial is testing

A Preliminary Exploratory Cohort Study of COVID-19 mRNA Vaccine, Bivalent in Participants Aged 18 Years and Over in China

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 54
Not applicableStudy completedNCT02150122
What this trial is testing

Dietary Requirement for Vitamin D in Adolescents Aged 14-18 Years

Who this might be right for
Serum 25-hydroxyvitamin D Concentrations (25OHD)
University of Surrey 120
Large-scale testing (Phase 3)Study completedNCT05107375
What this trial is testing

Clinical Study of Recombinant Novel Coronavirus（COVID-19） Vaccine (CHO Cell) Combined With Influenza Vaccine

Who this might be right for
Coronavirus Disease 2019
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 299
Testing effectiveness (Phase 2)Study completedNCT00327522
What this trial is testing

Safety and Immune Response Study of an Investigational Pneumococcal Vaccine.

Who this might be right for
Prophylactic Pneumococcal Diseases
GlaxoSmithKline 10
Load More Results